ZA972707B - Diclofenac/Gamma-CD inclusion compounds. - Google Patents

Diclofenac/Gamma-CD inclusion compounds.

Info

Publication number
ZA972707B
ZA972707B ZA9702707A ZA972707A ZA972707B ZA 972707 B ZA972707 B ZA 972707B ZA 9702707 A ZA9702707 A ZA 9702707A ZA 972707 A ZA972707 A ZA 972707A ZA 972707 B ZA972707 B ZA 972707B
Authority
ZA
South Africa
Prior art keywords
pct
diclofenac
gamma
date
sec
Prior art date
Application number
ZA9702707A
Other languages
English (en)
Inventor
Wilfried Fischer
Anna Sendl-Lang
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of ZA972707B publication Critical patent/ZA972707B/xx

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9702707A 1996-03-27 1997-03-27 Diclofenac/Gamma-CD inclusion compounds. ZA972707B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9600758A HUP9600758A2 (en) 1996-03-27 1996-03-27 Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption

Publications (1)

Publication Number Publication Date
ZA972707B true ZA972707B (en) 1997-10-22

Family

ID=89993834

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702707A ZA972707B (en) 1996-03-27 1997-03-27 Diclofenac/Gamma-CD inclusion compounds.

Country Status (13)

Country Link
US (1) US6071964A (de)
EP (1) EP0893994B1 (de)
JP (1) JP2000507258A (de)
CN (1) CN1217658A (de)
AT (1) ATE213410T1 (de)
AU (1) AU713902B2 (de)
BR (1) BR9708280A (de)
CA (1) CA2250009A1 (de)
DE (1) DE69710574D1 (de)
HU (1) HUP9600758A2 (de)
PL (1) PL329036A1 (de)
WO (1) WO1997035568A2 (de)
ZA (1) ZA972707B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2379854B (en) * 2001-09-19 2006-04-19 Walcom Animal Science Dairy cow feed and the use thereof
WO2003049753A1 (en) * 2001-12-13 2003-06-19 Council Of Scientific And Industrial Research Bioavailability enhancing activity of zingiber officinale linn and its extracts/fractions thereof
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
CN1232539C (zh) * 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
CN101410012A (zh) * 2006-03-28 2009-04-15 杰佛林制药公司 低剂量的非甾体抗炎药和β-环糊精的制剂
WO2007112272A2 (en) 2006-03-28 2007-10-04 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
JP2009196922A (ja) * 2008-02-21 2009-09-03 Glovia:Kk 徐放性フェルラ酸製剤
WO2009108828A2 (en) * 2008-02-27 2009-09-03 Dr. Reddy's Laboratories Ltd. Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
EP2422818A3 (de) * 2010-08-27 2013-01-16 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Verfahren zur Herstellung eines Diclofenac-Cyclodextrin Konjugates

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5984821A (ja) * 1982-11-04 1984-05-16 Teikoku Chem Ind Corp Ltd 徐溶化組成物
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1247529B (it) * 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
EP0519428B1 (de) * 1991-06-21 2000-09-20 Takeda Chemical Industries, Ltd. Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate
DE4207922A1 (de) * 1992-03-13 1993-09-23 Pharmatech Gmbh Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung
NZ267417A (en) * 1993-06-08 1997-02-24 Ciba Geigy Ag An inclusion compound of diclofenac and gamma-cyclodextrin and compressed dosage forms thereof
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
ATE213410T1 (de) 2002-03-15
CN1217658A (zh) 1999-05-26
CA2250009A1 (en) 1997-10-02
BR9708280A (pt) 1999-08-03
HU9600758D0 (en) 1996-05-28
EP0893994A2 (de) 1999-02-03
US6071964A (en) 2000-06-06
PL329036A1 (en) 1999-03-01
AU713902B2 (en) 1999-12-16
EP0893994B1 (de) 2002-02-20
WO1997035568A2 (en) 1997-10-02
DE69710574D1 (de) 2002-03-28
WO1997035568A3 (en) 1997-12-04
AU2382997A (en) 1997-10-17
HUP9600758A2 (en) 1998-03-02
JP2000507258A (ja) 2000-06-13

Similar Documents

Publication Publication Date Title
MX9504034A (es) Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas.
MY118151A (en) Pharmaceutical formulations containing voriconazole.
BG105459A (en) Pharmaceutical moxifloxacin preparation
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
HUP9701694A3 (en) Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
HUP9900773A3 (en) Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
DE69413237D1 (en) Plättchenaggregationsinhibitoren
SG162605A1 (en) Pharmaceutical compositions
NZ296573A (en) A free flowing powder comprises lamotrigine (or salt thereof), lactose, starch, crystalline cellulose, and polyvinylpyrrolidone
ZA972707B (en) Diclofenac/Gamma-CD inclusion compounds.
BG106293A (en) Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
DE69530123D1 (en) Plättchenaggregationsinhibitoren
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
UA41353C2 (uk) Похідні алкілбензоїлгуанідинів, спосіб їх одержання, фармацевтична композиція, що має аритмічну активність
IL113365A (en) 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
BG106151A (en) Pharmaceutical complex
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
HU9500175D0 (en) Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives
GB9420748D0 (en) 1,5 benzodiazepine derivatives
AU3433897A (en) 2-phenyl-3-azoylbenzothiophene for lowering intraocular pressure
DE69527129T2 (de) Esramustine formulierungen mit verbesserten eigenschaften
HU9401458D0 (en) Leukotriene-b4 derivatives, process for preparing the same and medicaments
BR9712628A (pt) Derivados de 8(9)-deidroestradiol